EVOLUTIS, founded in 1999, stands out as a French innovator in the orthopedic sector, emphasizing the design and manufacturing of high-quality joint implants. Over two decades, it has cemented its reputation for producing reliable and innovative products, including hip, shoulder, hand, and knee prostheses.
The company has a strong international presence, with operations in over 40 countries across all five continents, supported by a mix of commercial subsidiaries and exclusive distributors. This global reach is part of EVOLUTIS's strategic focus on expanding French orthopedic expertise worldwide, adapting to rising regulatory demands and local surgical requirements.
At its core, EVOLUTIS remains committed to retaining a human-sized corporate structure, fostering employee well-being and skill development. Its systems are ISO 13485 certified, aligning with international medical device standards, demonstrating its dedication to quality and compliance. The company's last financial backing was from Naxicap Partners in a Private Equity Round in 2011.